Huron Consulting Group Q3 2026 Results: Beat on Both Lines

As seen on the 24/7 Wall St. homepage on November 3, 2026.

HURN Huron Consulting Group
Q3 2026
EPS
$2.62
est $2.47 +5.9%
Revenue
$491M
est $481M +2.1%

Healthcare Managed Services revenue before reimbursables nearly doubled to $48.9 million, showing the RelateCare deal is already paying. Management narrowed full-year adjusted EPS guidance and the board lifted the buyback authorization to $1.1 billion through 2028.

Continue ReadingShow less

Huron Consulting Group reported third-quarter 2026 revenue of $491.5 million, up 11.4% from the same period a year earlier and beating expectations against the $481.4 million analyst consensus. Adjusted diluted EPS of $2.62 also beat expectations versus the $2.47 estimate, extending a streak in which Huron has topped the EPS consensus in every quarter shown in its recent history.

The standout driver was Healthcare Managed Services, where revenues before reimbursable expenses nearly doubled to $48.9 million. That surge was directly tied to the second-quarter acquisition of RelateCare, which added roughly 1,100 managed services professionals to Huron's headcount, with Managed Services professionals companywide more than doubling.

Organic growth also contributed across all three reporting segments, led by Healthcare at 16.5% with Education and Commercial each growing in the mid single digits. Consulting and Digital utilization both improved from a year ago, signaling stronger productivity even as headcount expanded.

Sponsored

GAAP results were softer than the adjusted figures. A $5.9 million non-cash credit loss on a convertible debt investment in a third party weighed $0.36 on GAAP diluted EPS, which came in at $1.75. Additionally, the Commercial segment saw operating income decline 9.9% with margin falling to 13.9%, a pocket of pressure worth watching against the otherwise broad-based strength.

Looking ahead, management narrowed full-year adjusted diluted EPS guidance to a range of $9.20 to $9.40, raising the midpoint, while affirming the revenue before reimbursables outlook. The board also expanded the share repurchase authorization to $1.1 billion and extended the program through December 31, 2028. Huron had already repurchased shares year to date at a pace that has meaningfully reduced the diluted share count and amplified per-share earnings growth.

Mentioned: HURN